Your browser version may not work well with NCBI's Web applications. More information here...
1: Am J Trop Med Hyg. 2004 Aug;71(2):187-9.Click here to read Links

Short report: the activity of pamaquine, an 8-aminoquinoline drug, against sporozoite-induced infections of Plasmodium vivax (New Guinea strains).

Sweeney AW, Blackburn CR, Rieckmann KH.

Institute for the Biotechnology of Infectious Diseases, University of Technology Sydney, Gore Hill, New South Wales, Australia. tony.sweeney@uts.edu.au

It was reported in 1946 that the administration of pamaquine during the incubation period delayed but did not prevent primary attacks of a New Guinea strain of Plasmodium vivax malaria. The observation that none of the four test subjects in this study had relapses has not previously been published and may have important implications for the evaluation of other 8-aminoquinoline compounds against relapsing vivax malaria.

PMID: 15306708 [PubMed - indexed for MEDLINE]